Difficulty: Medium
Average Score: 74%
Practice
The best treatment option for step-6 severe persistent asthma in a 6-year-old boy is
Correct answer
D
Rationale
In pediatric nursing, managing asthma in children requires a comprehensive understanding of treatment modalities based on severity. For a 6-year-old with step-6 severe persistent asthma, the best treatment option is option D: high-dose inhaled corticosteroids with long-acting B-agonist and oral corticosteroids along with omalizumab therapy.
This option is correct because step-6 severe persistent asthma necessitates aggressive treatment to control symptoms and prevent exacerbations. High-dose inhaled corticosteroids with long-acting B-agonists provide potent anti-inflammatory and bronchodilator effects. Oral corticosteroids help manage acute exacerbations, while omalizumab, a monoclonal antibody, is indicated for severe allergic asthma.
Option A is incorrect because medium-dose inhaled corticosteroids may not be sufficient for severe persistent asthma. Option B is insufficient as high-dose inhaled corticosteroids are required for severe asthma. Option C with low-dose inhaled corticosteroids is not appropriate for severe persistent asthma in a 6-year-old.
Educationally, understanding asthma severity levels and corresponding treatment strategies is crucial for nursing students caring for pediatric patients. This rationale highlights the importance of tailored, evidence-based approaches in managing pediatric asthma to optimize patient outcomes and quality of life.
This option is correct because step-6 severe persistent asthma necessitates aggressive treatment to control symptoms and prevent exacerbations. High-dose inhaled corticosteroids with long-acting B-agonists provide potent anti-inflammatory and bronchodilator effects. Oral corticosteroids help manage acute exacerbations, while omalizumab, a monoclonal antibody, is indicated for severe allergic asthma.
Option A is incorrect because medium-dose inhaled corticosteroids may not be sufficient for severe persistent asthma. Option B is insufficient as high-dose inhaled corticosteroids are required for severe asthma. Option C with low-dose inhaled corticosteroids is not appropriate for severe persistent asthma in a 6-year-old.
Educationally, understanding asthma severity levels and corresponding treatment strategies is crucial for nursing students caring for pediatric patients. This rationale highlights the importance of tailored, evidence-based approaches in managing pediatric asthma to optimize patient outcomes and quality of life.